marketsandmarkets presents n.
Skip this Video
Loading SlideShow in 5 Seconds..
Continuous Renal Replacement Therapy (CRRT) Market expected worth 1.1 Billion USD by 2020 PowerPoint Presentation
Download Presentation
Continuous Renal Replacement Therapy (CRRT) Market expected worth 1.1 Billion USD by 2020

Loading in 2 Seconds...

play fullscreen
1 / 7

Continuous Renal Replacement Therapy (CRRT) Market expected worth 1.1 Billion USD by 2020 - PowerPoint PPT Presentation

Download Presentation
Continuous Renal Replacement Therapy (CRRT) Market expected worth 1.1 Billion USD by 2020
An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. MarketsandMarkets Presents Continuous Renal Replacement Therapy (CRRT) Market– North America to offer significant growth opportunities

  2. The report “Continuous Renal Replacement Therapy (CRRT) Market by Products (System, Disposables (Hemofilters & Bloodlines), & Dialysate/Replacement Fluids), Modality (SCUF, CVVH, CVVHD, CVVHDF) and Geography - Regional Adoption and Global Forecasts to 2020”, analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and Rest of the World (RoW). Browse: 76market data tables 66figures 174pages and in-depth TOC on "Continuous Renal Replacement Therapy (CRRT) Market” Download The PDF Brochure@ This report studies the global CRRT market over the forecast period of 2015 to 2020. The market is expected to reach USD 1.1 Billion by 2020 at CAGR of 7.2% from 2015 to 2020.

  3. On the basis of product, the CRRT market is classified into CRRT systems, CRRT disposables, and dialysate & replacement fluids. The diagnostic CRRT disposables segment is further divided into hem filters, bloodlines, and other disposables. Ask For Discount on this Report@ On the basis of modality, the CRRT market is categorized into slow continuous ultrafiltration (SCUF), continuous venovenous hemofiltration (CVVH), continuous venovenous hemodialysis (CVVHD), and continuous venovenoushemodiafiltration (CVVHDF).

  4. Factors such as growing aging population, increasing number of AKI patients, technological advancements & new product launches, rising adoption of CRRT for the treatment of renal disorders, and clinical advantages of CRRT over intermittent blood purification techniques are driving the growth of the global CRRT market. However, factors such as the high complexity & procedural costs of CRRT therapy and a dearth of trained ICU nurses across the globe have been hampering the growth of this market. Europe is estimated to account for the largest share of the market in 2015, followed by North America. However, the Asia-Pacific market is expected to grow at the highest CAGR of ~8.7% from 2015 to 2020. This high growth can be attributed to the rapidly increasing aging population, rising sepsis incidence, growing focus of multinational companies on emerging markets, and improving and modernizing healthcare infrastructure in this region.

  5. Some major players in the global CRRT market are Asahi Kasei Medical Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Baxter International Inc. (U.S.), BellcoS.r.l. (Italy), Fresenius Medical Care AG & Co. KGaA (Germany), Infomed SA (Switzerland), Medica S.p.A (Italy), Medical Components, Inc. (U.S.), Nikkiso Co., Ltd (Japan), NxStage Medical, Inc. (U.S.), and Toray Medical Company Limited (Japan).

  6. About MarketsandMarkets™ MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

  7. Contact Us Mr. Rohan MarketsandMarkets™ 701 Pike Street Suite 2175, Seattle, WA 98101, United States Tel: 1-888-600-6441 Email: sales@marketsandmarkets.comMarketsandMarkets Bloghttp://www.marketsandmarkets.com